Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122918534 | 12291853 | 4 | F | 20160701 | 20160421 | 20160711 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-029231 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160711 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122918534 | 12291853 | 1 | PS | SPRYCEL | DASATINIB | 1 | Oral | 100 MG, QD | U | U | 5H71814C | 21986 | 100 | MG | QD | ||||
| 122918534 | 12291853 | 2 | SS | SPRYCEL | DASATINIB | 1 | Unknown | 100MG | U | U | 21986 | ||||||||
| 122918534 | 12291853 | 3 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 20 MG, QD | U | U | 0 | 20 | MG | QD | |||||
| 122918534 | 12291853 | 4 | C | MAGNESIUM | MAGNESIUM | 1 | Unknown | U | U | 0 | |||||||||
| 122918534 | 12291853 | 5 | C | TYLENOL | ACETAMINOPHEN | 1 | Unknown | U | U | 0 | |||||||||
| 122918534 | 12291853 | 6 | C | CODEINE | CODEINE | 1 | Unknown | U | U | 0 | |||||||||
| 122918534 | 12291853 | 7 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122918534 | 12291853 | 1 | Fibrous dysplasia of bone |
| 122918534 | 12291853 | 2 | White blood cell disorder |
| 122918534 | 12291853 | 3 | Product used for unknown indication |
| 122918534 | 12291853 | 4 | Product used for unknown indication |
| 122918534 | 12291853 | 5 | Product used for unknown indication |
| 122918534 | 12291853 | 6 | Product used for unknown indication |
| 122918534 | 12291853 | 7 | Constipation |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122918534 | 12291853 | Abdominal distension | |
| 122918534 | 12291853 | Anxiety | |
| 122918534 | 12291853 | Chest pain | |
| 122918534 | 12291853 | Constipation | |
| 122918534 | 12291853 | Diarrhoea | |
| 122918534 | 12291853 | Dyspnoea | |
| 122918534 | 12291853 | Feeling abnormal | |
| 122918534 | 12291853 | Fungal infection | |
| 122918534 | 12291853 | Hypersensitivity | |
| 122918534 | 12291853 | Insomnia | |
| 122918534 | 12291853 | Off label use | |
| 122918534 | 12291853 | Pruritus | |
| 122918534 | 12291853 | Rash | |
| 122918534 | 12291853 | Stress | |
| 122918534 | 12291853 | Tension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122918534 | 12291853 | 1 | 201507 | 0 | ||
| 122918534 | 12291853 | 2 | 20150714 | 0 |